World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
107
Citations
55812
World Ranking
6137
National Ranking
3280

Overview

Suzanne Craft is affiliated with Wake Forest University in the United States and has a significant body of research primarily within the field of Medicine. Their work spans several subfields, including Physiology, Psychiatry and Mental Health, Molecular Biology, Radiology, Nuclear Medicine and Imaging, and Neurology.

The scientist's research focuses on several key topics, such as:

  • Dementia and Cognitive Impairment Research
  • Alzheimer's Disease Research and Treatments
  • Diet and Metabolism Studies
  • Advanced Neuroimaging Techniques and Applications
  • Cerebrovascular and Carotid Artery Diseases
  • Nutritional Studies and Diet
  • Functional Brain Connectivity Studies

Recent notable papers include the following:

  • Brain insulin resistance in Alzheimer's disease and related disorders: mechanisms and therapeutic approaches, 2020, The Lancet Neurology
  • Safety, Efficacy, and Feasibility of Intranasal Insulin for the Treatment of Mild Cognitive Impairment and Alzheimer Disease Dementia, 2020, JAMA Neurology
  • Senolytic therapy in mild Alzheimer's disease: a phase 1 feasibility trial, 2023, Nature Medicine
  • Gut mycobiome and its interaction with diet, gut bacteria and Alzheimer's disease markers in subjects with mild cognitive impairment: A pilot study, 2020, EBioMedicine
  • Senolytic Therapy to Modulate the Progression of Alzheimer's Disease (SToMP-AD): A Pilot Clinical Trial, 2021, The Journal of Prevention of Alzheimer's Disease

The scientist frequently collaborates with various co-authors, including:

  • Samuel N. Lockhart
  • Christopher T. Whitlow
  • James R. Bateman
  • Thomas C. Register
  • Timothy M. Hughes

Key publication venues where their work appears include:

  • Alzheimer's & Dementia
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Innovation in Aging
  • Journal of Alzheimer's Disease
  • Alzheimer's & Dementia Translational Research & Clinical Interventions

Best Publications

  • Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

    Reisa A. Sperling;Paul S. Aisen;Laurel A. Beckett;David A. Bennett

  • Intranasal Insulin Therapy for Alzheimer Disease and Amnestic Mild Cognitive Impairment

    Suzanne Craft;Laura D. Baker;Thomas J. Montine;Satoshi Minoshima

  • Effects of aerobic exercise on mild cognitive impairment: a controlled trial.

    Laura D. Baker;Laura L. Frank;Karen Foster-Schubert;Pattie S. Green

  • Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums

    Steven E. Arnold;Zoe Arvanitakis;Shannon L. Macauley-Rambach;Aaron M. Koenig

  • Insulin and neurodegenerative disease: shared and specific mechanisms

    Suzanne Craft;G Stennis Watson

  • Glucose Levels and Risk of Dementia

    Paul K. Crane;Rod Walker;Rebecca A. Hubbard;Ge Li

  • Intranasal insulin improves cognition and modulates β-amyloid in early AD

    M. A. Reger;G. S. Watson;P. S. Green;C. W. Wilkinson

  • Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's disease.

    M E Risner;A M Saunders;J F B Altman;G C Ormandy

  • Effects of intranasal insulin on cognition in memory-impaired older adults: modulation by APOE genotype.

    M.A. Reger;M.A. Reger;G.S. Watson;G.S. Watson;W.H. Frey;W.H. Frey;L.D. Baker;L.D. Baker

  • Insulin resistance and Alzheimer-like reductions in regional cerebral glucose metabolism for cognitively normal adults with prediabetes or early type 2 diabetes.

    Laura D. Baker;Donna J. Cross;Satoshi Minoshima;Dana Belongia

  • Cerebrospinal fluid and plasma insulin levels in Alzheimer's disease: relationship to severity of dementia and apolipoprotein E genotype.

    Suzanne Craft;Elaine Peskind;Michael W. Schwartz;Gerard D. Schellenberg

  • Effect of Vitamin E and Memantine on Functional Decline in Alzheimer Disease The TEAM-AD VA Cooperative Randomized Trial

    Maurice W. Dysken;Mary Sano;Sanjay Asthana;Julia E. Vertrees

  • Decreased memory performance in healthy humans induced by stress-level cortisol treatment.

    John W. Newcomer;Gregg Selke;Angela K. Melson;Tamara Hershey

  • A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease

    R. Scott Turner;Ronald G. Thomas;Suzanne Craft;Christopher H. van Dyck

  • Ketamine-Induced NMDA Receptor Hypofunction as a Model of Memory Impairment and Psychosis

    John W Newcomer;Nuri B Farber;Vesna Jevtovic-Todorovic;Gregg Selke

  • The Role of Metabolic Disorders in Alzheimer Disease and Vascular Dementia: Two Roads Converged

    Suzanne Craft

  • Vascular contributions to cognitive impairment and dementia including Alzheimer's disease

    Heather M. Snyder;Roderick A. Corriveau;Suzanne Craft;James E. Faber

  • Effects of β-hydroxybutyrate on cognition in memory-impaired adults

    Mark A. Reger;Samuel T. Henderson;Cathy Hale;Brenna Cholerton;Brenna Cholerton

  • Memory improvement following induced hyperinsulinemia in alzheimer's disease

    Suzanne Craft;John Newcomer;Stephen Kanne;Samuel Dagogo-Jack

  • Insulin resistance and Alzheimer's disease pathogenesis: potential mechanisms and implications for treatment.

    Suzanne Craft

Frequent Co-Authors

Laura D. Baker
Laura D. Baker Wake Forest University
Sanjay Asthana
Sanjay Asthana University of Wisconsin–Madison
Stephen R. Plymate
Stephen R. Plymate University of Washington
Thomas J. Montine
Thomas J. Montine Stanford University
Elaine R. Peskind
Elaine R. Peskind University of Washington
Mark A. Reger
Mark A. Reger University of Washington
James B. Leverenz
James B. Leverenz Cleveland Clinic
Murray A. Raskind
Murray A. Raskind University of Washington
Charles W. Wilkinson
Charles W. Wilkinson University of Washington
Gerard D. Schellenberg
Gerard D. Schellenberg University of Pennsylvania

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Interested in healthcare but not sure if a traditional medical degree is right for you? There are several related online degrees and accelerated career pathways worth exploring. For nurses aiming to reach the highest levels of clinical practice, consider the easiest dnp programs that offer flexible formats and streamlined coursework for working professionals.

If you are looking to jumpstart your career quickly, fast track medical lpn programs provide an efficient route to becoming a licensed practical nurse—often in less than a year—fully online.

Mental health professionals with a master's degree can also advance rapidly through the shortest post master's pmhnp online programs, specializing in psychiatric-mental health nurse practice.

For those more interested in the business and leadership side of healthcare, an online healthcare administration degree can open doors to in-demand management roles, often at an affordable cost and at your own pace.

Each pathway offers unique advantages, making it possible to find a healthcare career that fits your interests, lifestyle, and long-term professional goals.

Best Scientists Citing Suzanne Craft

Trending Scientists